Context Therapeutics (CNTX) Q2 2026 Earnings

May 6Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.11
-0.09
-0.07
-0.05

Details

Expected EPS
-0.111278
Actual EPS
-0.09
Surprise EPS
0.02
Surprise Percent
+19.12%

Description

⁨Context Therapeutics⁩ (⁦CNTX⁩) has reported earnings of ⁦-0.09⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts